The drug firm Torrent Pharmaceuticals announced a 27.04percent rise in consolidated net profit to Rs 310 crore for the quarter ended September mainly on account of robust sales in India and reduction in expenses.
India revenues at Rs 963 crores grew by 7% versus the IPM growth 1% for the quarter as per AIOCD.Torrent pharmaceuticals said in release.
Torrent Pharma is a specialty- focused company with 75% of its revenue in India from chronic and sub-chronic therapies.
Diabetes is a chronic condition that affects how your body processes blood sugar (glucose). When…
A recent study published in the journal Clinical Nutrition highlights significant concerns regarding ultra-processed foods…
Air pollution is often portrayed as an environmental concern, but its impact on human health…
Delhi, the bustling capital of India, has long been grappling with an escalating environmental crisis—air…
The air quality in Delhi deteriorates significantly every year as the city approaches winter. This…
The "Rwanda Virus," commonly known as the Marburg virus, is a highly infectious pathogen responsible…